Comorbidity-related treatment outcomes among HIV-Infected adults in the Bronx, NY

Journal of Urban Health

Volumn 88, Issue 3, 2011, Pages 507-516

  Chu, Carolyn ^a   Umanski, Galina ^a   Blank, Arthur ^a   Meissner, Paul ^a   Grossberg, Robert ^a   Selwyn, Peter A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Combination antiretroviral therapy; Comorbidities and HIV; Treatment outcomes and HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE; ARTICLE; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUG COMBINATION; DYSLIPIDEMIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MALE; MIDDLE AGED; OUTPATIENT DEPARTMENT; PREVALENCE; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGE FACTORS; ANTI-HIV AGENTS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NEW YORK CITY; OUTPATIENT CLINICS, HOSPITAL; PREVALENCE; TREATMENT OUTCOME;

EID: 80052963403     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-010-9540-7     Document Type: Article

References (22)

1. Justman JE, Benning L, Danoff A, et al. Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. J Acquir Immune Defic Syndr. 2003; 32(3): 298-302. (Pubitemid 36331702)
2. Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005; 165 (10): 1179-84. (Pubitemid 40720744)
3. Glass TR, Ungsedhapand C, Wolbers M, et al. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV cohort study. HIVMed. 2006; 7(6): 404-10. (Pubitemid 44123252)
4. Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006; 43(1): 27-34. (Pubitemid 44306484)
5. Adeyemi O, Vibhakar S, Max B. Are we meeting the American Diabetes Association goals for HIV-infected patients with diabetes mellitus? Clin Infect Dis. 2009; 49(5): 799-802.
6. Bury JE, Stroup JS, Stephens JR, Baker DL. Achieving American Diabetes Association goals in HIV-seropositive patients with diabetes mellitus. Proc Bayl Univ Med Cent. 2007; 20(2): 118-23
7. Centers for Disease Control and Prevention. HIV prevalence estimates-United States, 2006. MMWR. 2008; 57(39): 1073-6.
8. Link CL, Mc Kinlay JB. Disparities in the prevalence of diabetes: is it race/ethnicity or socioeconomic status? Results from the Boston Area Community Health (BACH) survey. Ethn Dis. 2009; 19(3): 288-92.
9. Clark AM, Des Meules M, Luo W, Duncan AS, Wielgosz A. Socioeconomic status and cardiovascular disease: risks andimplications for care. Nat Rev Cardiol. 2009; 6(11): 712-22.
10. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2009; 49(5): 651-81.
11. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003; 289(19): 2560-72. (Pubitemid 37430158)
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285 (19):2486-97
13. American Diabetes Association. Standards ofmedical care in diabetes-2008. Diab Care. 2008; 31(Suppl 1): S12-54.
14. Jung O, Bickel M, Ditting T, et al. Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrity. Nephrol Dial Transplant. 2004; 19(9): 2250-8. (Pubitemid 39214118)
15. Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN. Prevalence of hypertension in HIV-positive patients on highly active antiretroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis. 2003; 22(12): 731-6. (Pubitemid 38019313)
16. Crum-Cianflone N, Tejidor R, Medina S, Barahona I, Ganesan A. Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDs. 2008; 22(12): 925-30.
17. Korthuis PT, Asch SM, Anaya HD, et al. Lipid screening in HIV-infected veterans. J Acquir Immune Defic Syndr. 2004; 35(3): 253-60. (Pubitemid 38280650)
18. Bell TJ, Tang S, Jamieson MJ. Evaluation of hypertension prevalence and blood pressure goal attainment using data from the 1999-2000 national health and nutrition examination survey (NHANES). Am JHypertens. 2004; 17(5): S193
19. Pearson TA, Laurora L, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemia patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000; 160(4): 459-67. (Pubitemid 30112269)
20. Beaton SJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM. Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care settings. Diab Care. 2004; 27(3): 694-8. (Pubitemid 38280535)
21. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004; 291(3): 335-42. (Pubitemid 38101606)
22. Justice AC Prioritizing primary care in HIV: comorbidity, toxicity, and demography. Top HIV Med. 2006; 14(5): 159-63.